Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Arzeda Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10855
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:16
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Arzeda Corp (Arzeda) is a biotechnology company that develops biological solutions for transformative products. The company’s products include novel crop traits, 1, 3-butadiene, levulinic acid, and methane. Its services comprise enzyme design, metabolic engineering, and protein optimization services. Arzeda utilizes natural environments for bulk synthesis that carries manufacture of important universal industrial building blocks such as butanol, isoprene or adipic acid; and potential to create building block precursors with different properties. The company designs cell factories for producing specialty and bulk chemicals. Its products are used for improvement of both crop yields and farming resource efficiency. The company partners with agriculture and biotech partners to develop novel products. Arzeda is headquartered in Seattle, Washington, the US.

Arzeda Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Corp, Pharmaceuticals & Healthcare, Deal Details 9
Venture Financing 9
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Partnerships 11
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp – Key Competitors 12
Arzeda Corp – Key Employees 13
Arzeda Corp – Locations And Subsidiaries 14
Head Office 14
Recent Developments 15
Corporate Communications 15
Dec 21, 2017: Arzeda Strengthens Board of Directors with Addition of Biotechnology Veteran William Baum 15
Appendix 16
Methodology 16
About GlobalData 16
Contact Us 16
Disclaimer 16

List of Tables
Arzeda Corp, Pharmaceuticals & Healthcare, Key Facts 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Arzeda Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 8
Arzeda Raises Additional USD3.2 Million in Series A Financing 9
Arzeda Raises USD12 Million in Series A Financing 10
Zymergen Enters into Co-Development Agreement with Arzeda 11
Arzeda Corp, Key Competitors 12
Arzeda Corp, Key Employees 13

List of Figures
Arzeda Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Arzeda Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Arzeda Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

★海外企業調査レポート[Arzeda Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • S.C. Termoelectrica SA:企業の戦略的SWOT分析
    S.C. Termoelectrica SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • Packaging Corporation of America (PKG):企業の財務・戦略的SWOT分析
    Packaging Corporation of America (PKG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Immunomic Therapeutics Inc-製薬・医療分野:企業M&A・提携分析
    Summary Immunomic Therapeutics Inc (ITI) is a biotechnology company that specializes in developing vaccines based on the patented lysosomal associated membrane protein or lamp technology. The company's pipeline product portfolio drugs for allergy vaccine therapy and oncology immunotherapy. It develo …
  • AtriCure Inc (ATRC):企業の財務・戦略的SWOT分析
    AtriCure Inc (ATRC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Valensa International LLC:企業の戦略・SWOT・財務情報
    Valensa International LLC - Strategy, SWOT and Corporate Finance Report Summary Valensa International LLC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Sojitz Corporation:企業の戦略・SWOT・財務分析
    Sojitz Corporation - Strategy, SWOT and Corporate Finance Report Summary Sojitz Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Hiscox Ltd:戦略・SWOT・企業財務分析
    Hiscox Ltd - Strategy, SWOT and Corporate Finance Report Summary Hiscox Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Omega Protein Corporation:企業の戦略・SWOT・財務情報
    Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report Summary Omega Protein Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Shanghai Fosun Pharmaceutical (Group) Co Ltd (600196)-製薬・医療分野:企業M&A・提携分析
    Summary Shanghai Fosun Pharmaceutical (Group) Co Ltd (Fosun Pharma), a subsidiary of Shanghai Fosun High Technology (Group) Co Ltd is a drug company that offers pharmaceutical products, medical diagnostic products and medical device products. The company’s pharmaceutical products include metabolism …
  • Vivus Inc (VVUS):企業の財務・戦略的SWOT分析
    Vivus Inc (VVUS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Medical Transcription Billing Corp (MTBC):医療機器:M&Aディール及び事業提携情報
    Summary Medical Transcription Billing Corp (MTBC) is a healthcare IT company that offers web-based solutions and related business services. The company offers products such as electronic health records, practice management, patient engagement and mhealth. Its services include offers medical billing, …
  • InTouch Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary InTouch Technologies Inc (InTouch Health) is a healthcare technology company that provides Telehealth Network, comprised of telehealth systems, clinical workflow solutions, software and managed services to healthcare systems and hospitals for the delivery of clinical care. The company’s tele …
  • AcelRx Pharmaceuticals Inc (ACRX)-医療機器分野:企業M&A・提携分析
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of pain. The company’s lead product candidate, DSUVIA (known as ARX-04 outside the US), is a single sufentanil sublingual tablet for the treatment of …
  • Twist Bioscience Corp:医療機器:M&Aディール及び事業提携情報
    Summary Twist Bioscience Corp (Twist Bioscience) is a DNA specializing and development company that develops DNA products ad DNA synthesis process. The company provides products includes DNA pools for gRNA cloning such as unamplified oligo pools, cloning-ready oligo pools; protein scanning single va …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) is a technology company that carries out manufacturing of electron tube. The company offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equip …
  • Exterran Corp (EXTN):企業の財務・戦略的SWOT分析
    Exterran Corp (EXTN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Vior Inc (VIO):企業の財務・戦略的SWOT分析
    Summary Vior Inc (Vior) is a mining and mineral exploration company. The company carries out the business of acquisition, exploration, and development of gold and silver metal properties in North and Latin America. Its projects comprise Mosseau Gold project, Foothills Rutile project, Vezza-Noyard Go …
  • Cell C (Pty) Ltd.:企業の戦略・SWOT・財務情報
    Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report Summary Cell C (Pty) Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • AJ Lucas Group Ltd (AJL):企業の財務・戦略的SWOT分析
    AJ Lucas Group Ltd (AJL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Innate Pharma SA (IPH):企業の財務・戦略的SWOT分析
    Summary Innate Pharma SA (Innate Pharma) is a healthcare products provider that develops immunopharmacology and antibody technology products. The company carries out the discovery and development of therapeutic antibodies for the treatment of cancer and inflammatory diseases. It develops new monoclo …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆